Hallucinogens and dissociative agents naturally growing in the United States

Pharmacology and Therapeutics

Volumn 102, Issue 2, 2004, Pages 131-138

  Halpern, John H ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Anticholinergic; DEA; DMT; Drug Enforcement Administration; Drug use; Hallucinogens; Intoxication; LSA; LSD; lysergic acid amide; lysergic acid diethylamide; MAOI; monoamine oxidase inhibitor; N,N dimethyltryptamine; NAC; Native American Church; Plants; Religion; spp.

Indexed keywords

1,2,3,4 TETRAHYDROHARMINE; ATROPINE; AYAHUASCA; CHOLINERGIC RECEPTOR BLOCKING AGENT; DITERPENE; HARMALINE; HARMINE; IBOTENIC ACID; LYSERGIC ACID; MESCALINE; MONOAMINE OXIDASE INHIBITOR; MUSCIMOL; N,N DIMETHYLTRYPTAMINE; PLANT EXTRACT; PSILOCIN; PSILOCYBINE; PSYCHEDELIC AGENT; SCOPOLAMINE; UNCLASSIFIED DRUG;

ALCOHOLISM; AMANITA MUSCARIA; AMANITA PANTHERINA; BRADYCARDIA; CONFERENCE PAPER; COURT; CRIMINAL JUSTICE; DRUG ACTIVITY; DRUG DEPENDENCE; DRUG INFORMATION; DRUG SYNTHESIS; GEOGRAPHY; GOVERNMENT; HEALTH HAZARD; HUMAN; INGESTION; INTERNET; INTOXICATION; LAW ENFORCEMENT; LEGAL ASPECT; MEDICAL INFORMATION; MOTION SICKNESS; MUSHROOM; PLANT; PLANT GROWTH; PRIORITY JOURNAL; RELIGION; SALVIA DIVINORUM; SCIENCE; SEDATION; SUBSTANCE ABUSE; TEA; TRADITIONAL MEDICINE; UNITED STATES;

DISSOCIATIVE DISORDERS; FUNGI; HALLUCINOGENS; IBOTENIC ACID; MUSCIMOL; N,N-DIMETHYLTRYPTAMINE; PLANTS; UNITED STATES;

EID: 2542460170     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.03.003     Document Type: Conference Paper

References (61)

1. Agurell S. Cactaceae alkaloids I. Lloydia. 32:1969;206-216
2. Al Assmar S.E. The seeds of the Hawaiian baby woodrose are a powerful hallucinogen. Arch Intern Med. 159:1999;2090
3. Ardila A., Moreno C. Scopolamine intoxication as a model of transient global amnesia. Brain Cogn. 15:1991;236-245
4. Arnett A. Jimson weed poisoning. Clin Toxicol Rev. 18:1995;1-2
5. Arora D. Mushrooms Demystified: A Comprehensive Guide to the Fleshy Fungi. 1990;Ten Speed Press, Berkeley, CA
6. Barker R.E., Hovin A.W. Inheritance of indole alkaloids in reed canary grass (Phalaris arundinacea L.). I. Heritability estimates for alkaloid concentration. Crop Sci. 14:1974;50-53
7. Baxter C., Slaytor M. Biosynthesis and turnover of N, N-dimethyltryptamine and 5-methoxy-N, N-dimethyltryptamine in Phalaris tuberosa. Phytochemistry. 11:1972;2767-2773
8. Borsutzky M., Passie T., Paetzold W., Emrich H.M., Schneider U. Hawaiian baby woodrose: (Psycho-)pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration. Nervenarzt. 73:2002;892-896
9. Brown J.H., Taylor P. Muscarinic receptor agonists and antagonists. Hardman J.G., Limbird L.E., Gilman A.G. Goodman and Gillman's The Pharmacologic Basis of Therapeutics. 2001;155-174 McGraw-Hill, New York
10. Callaway J.C., Raymon L.P., Hearn W.L., McKenna D.J., Grob C.S., Brito G.S., Mash D.C. Quantitation of N, N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca. J Anal Toxicol. 20:1996;492-497
11. Carlini E.A. Plants and the central nervous system. Pharmacol Biochem Behav. 75:2003;501-512
12. Chao J.M., Der Marderosian A.H. Ergoline alkaloidal constituents of Hawaiian baby wood rose, Argyreia nervosa (Burm. f.) Bojer. J Pharm Sci. 62:1973;588-591
13. Crosby D., McLaughlin J. Cactus alkaloids: XIX. Crystallization of mescaline HCl and 3-methoxytyramine HCl from Trichocereus pachanoi. Lloydia. 36:1973;416-418
14. de Rios M.D., Grob C.S., Baker J.R. Hallucinogens and redemption. J Psychoact Drugs. 34:2002;239-248
15. Grella B., Dukat M., Young R., Teitler M., Herrick-Davis K., Gauthier C.B., Glennon R.A. Investigation of hallucinogenic and related beta-carbolines. Drug Alcohol Depend. 50:1998;99-107
16. Grinspoon L., Bakalar J.B. Psychedelic Drugs Reconsidered. 1997;The Lindesmith Center, New York
17. Grob C.S., McKenna D.J., Callaway J.C., Brito G.S., Neves E.S., Oberlaender G., Saide O.L., Labigalini E., Tacla C., Miranda C.T., Strassman R.J., Boone K.B. Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis. 184:1996;86-98
18. Halpern J.H. The use of hallucinogens in the treatment of addiction. Addict Res. 4:1996;177-189
19. Halpern J.H., Pope H.G. Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry. 15:2001;481-483
20. Hashimoto H., Clyde V.J., Parko K.L. Botulism from peyote. N Engl J Med. 339:1998;203-204
21. Helmlin H.J., Brenneisen R. Determination of psychotropic phenylalkylamine derivatives in biological matrices by high-performance liquid chromatography with photodiode-array detection. J Chromatogr. 593:1992;87-94
22. Hoffer A., Osmond H. New Hope for Alcoholics. 1968;University Books, New Hyde Park, NY
23. Isbell H., Wolbach A.B., Wikler A., Miner E.J. Cross tolerance between LSD and psilocybin. Psychopharmacologia. 2:1961;147-159
24. Johnston L.D., O'Malley P.M., Bachman J.G. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2002. 2003;National Institute on Drug Abuse, Bethesda, MD
25. Kapadia G.J., Fayez M.B. The chemistry of peyote alkaloids. Lloydia. 36:1973;9-35
26. Kluckhohn C. Navaho Witchcraft. 1944;Beacon Press, Boston, MA
27. Lindenblatt H., Kraemer E., Holzmann-Erens P., Gouzoulis-Mayfrank E., Kovar K.A. Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction. J Chromatogr B Biomed Sci Appl. 709:1998;255-263
28. Lohrer F., Kaiser R. Biological hallucinogens. New patterns of substance abuse in young addicts? Nervenarzt. 70:1999;1029-1033
29. Mack J.P.G., Mulvena D.P., Slaytor M. N, N-Dimethyltryptamine production in Phalaris aquatica seedlings: a mathematical model for its synthesis. Plant Physiol. 88:1988;315-320
30. McKenna D.J., Towers G.H., Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol. 10:1984;195-223
31. Miller M.D. Isolation and identification of lysergic acid amide and isolysergic acid amide as the principal ergoline alkaloids in Argyreia nervosa, a tropical wood rose. J AOAC. 53:1970;123-127
32. Musshoff F., Madea B., Beike J. Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. Forensic Sci Int. 113:2000;389-395
33. Naranjo C. Psychotropic properties of the harmala alkaloids. Efron D.H., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. Vol. 1645:1979;385-391 U.S. Public Health Service Publication, Washington, DC
34. National Drug Intelligence Center Information bulletin: Salvia divinorum. Microgram. XXXVI:2003;122-125
35. Pardanani J., McLaughlin J., Kondrat R., Cooks R. Cactus alkaloids. XXXVI. Mescaline and related compounds from Trichocereus peruvianus. Lloydia. 40:1977;585-590
36. Pennes H.H., Hoch P.H. Psychotomimetics, clinical and theoretical considerations: harmine, WIN-2299 and nalline. Am J Psychiatry. 113:1957;887-892
37. Petroski R.J., Powell R.G., Clay K. Alkaloids of Stipa robusta (sleepygrass) infected with an Acremonium endophyte. Nat Toxins. 1:1992;84-88
38. Riba J., Anderer P., Morte A., Urbano G., Jane F., Saletu B., Barbanoj M.J. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br J Clin Pharmacol. 53:2002;613-628
39. Riba J., Rodriguez-Fornells A., Barbanoj M.J. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacology (Berl). 165:2002;18-28
40. Riba J., Rodriguez-Fornells A., Urbano G., Morte A., Antonijoan R., Montero M., Callaway J.C., Barbanoj M.J. Subjective effects and tolerability of the South American psychoactive beverage ayahuasca in healthy volunteers. Psychopharmacology (Berl). 154:2001;85-95
41. Riba J., Valle M., Urbano G., Yritia M., Morte A., Barbanoj M.J. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion and pharmacokinetics. J Pharmacol Exp Ther. 306:2003;73-83
42. Rivier L., Lindgren J.E. Ayahuasca, the South American hallucinogenic drink: an ethnobotanical and chemical investigation. Econ Bot. 29:1972;101-129
43. Roth B.L., Baner K., Westkaemper R., Siebert D., Rice K.C., Steinberg S., Ernsberger P., Rothman R.B. Salvinorin A: a potent naturally occurring nonnitrogenous κ opioid selective agonist. Proc Natl Acad Sci USA. 99:2002;11934-11939
44. Schultes R.E. Hallucinogens of plant origin. Science. 163:1969;245-254
45. Schultes R.E., Hofmann A. The Botany and Chemistry of Hallucinogens. 1980;Charles C. Thomas, Springfield, IL
46. Schultes R.E., Hofmann A. Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers. 1992;Healing Arts Press, Rochester, VT
47. Shulgin A., Shulgin A. TIHKAL: The Continuation. 1997;Transform Press, Berkeley, CA
48. Siebert D. Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol. 43:1994;53-56
49. Slotkin T.A., DiStefano V., Au W.Y.W. Blood levels and urinary excretion of harmine and its metabolites in man and rats. J Pharmacol Exp Ther. 173:1970;26-30
50. Stamets P. Psilocybin Mushrooms of the World: An Identification Guide. 1996;Ten Speed Press, Berkeley, CA
51. Stewart O. Peyote Religion: A History. 1987;University of Oklahoma Press, Tulsa, OK
52. Strassman R.J. Human psychopharmacology of N, N-dimethyltryptamine. Behav Brain Res. 73:1996;121-124
53. Strassman R.J. DMT: The Spirit Molecule. 2001;Park Street Press, Rochester, VT
54. Thompson A.C., Nicollier G.F., Pope D.F. Indolealkylamines of Desmanthus illinoensis and their growth inhibition activity. J Agric Food Chem. 35:1987;361-365
55. Turner D.M. The Essential Psychedelic Guide. 1994;Panther Press, San Francisco, CA
56. USDA, NRCS The PLANTS Database (3.5). 2004;National Plant Data Center, Baton Rouge, LA
57. Valdes L.J., Diaz J., Paul A. Ethnopharmacology of Ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.). J Ethnopharmacol. 7:1983;287-312
58. Waser F.G. The pharmacology of Amanita muscaria. Efron D.H., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. Vol. 1645:1979;419-439 U.S. Public Health Service Publication, Washington, DC
59. Wasson R.G. The hallucinogenic fungi of Mexico: An inquiry into the origins of the religious idea among primitive peoples. Bot Mus Leaf, Harv Univ. 19:1961;137-162
60. Wasson R.G. A new Mexican psychotropic drug from the mint family. Bot Mus Leaf, Harv Univ. 20:1962;77-84
61. Wasson R.G. Fly Agaric and Man. Efron D.H., Holmstedt B., Kline N.S. Ethnopharmacologic Search for Psychoactive Drugs. U.S. Public Health Service Publication, No. 1645. 1979;405-414 U.S. Public Health Service, Washington, DC